Medical Innovation Exchange

Novartis suspends dosing in phase 2b Huntington's trial after side effects reported

https://www.fiercebiotech.com/biotech/novartis-suspends-dosing-phase-2b-huntingtons-disease-trial-after-side-effects-reported

Leave a Comment

Your email address will not be published.

Leave the field below empty!